Breast cancer versus hormone therapy of the menopausal period

Tomasz Pertyński; Grzegorz Stachowiak

Abstract

3/2005 vol. 4

Breast cancer versus hormone therapy of the menopausal period

Tomasz Pertyński

,

Grzegorz Stachowiak

Prz Menopauz 2005; 3: 47–52

Online publish date: 2005/06/09

View full text

AMA

Pertyński T, Stachowiak G. Breast cancer versus hormone therapy of the menopausal period. Menopause Review/Przegląd Menopauzalny. 2005;4(3):47-52.

APA

Pertyński, T., & Stachowiak, G. (2005). Breast cancer versus hormone therapy of the menopausal period. Menopause Review/Przegląd Menopauzalny, 4(3), 47-52.

Chicago

Pertyński, Tomasz, and Grzegorz Stachowiak. 2005. "Breast cancer versus hormone therapy of the menopausal period". Menopause Review/Przegląd Menopauzalny 4 (3): 47-52.

Harvard

Pertyński, T., and Stachowiak, G. (2005). Breast cancer versus hormone therapy of the menopausal period. Menopause Review/Przegląd Menopauzalny, 4(3), pp.47-52.

MLA

Pertyński, Tomasz et al. "Breast cancer versus hormone therapy of the menopausal period." Menopause Review/Przegląd Menopauzalny, vol. 4, no. 3, 2005, pp. 47-52.

Vancouver

Pertyński T, Stachowiak G. Breast cancer versus hormone therapy of the menopausal period. Menopause Review/Przegląd Menopauzalny. 2005;4(3):47-52.

In this article some data on the connection between sex steroids and mammary gland development, mitosis, apoptosis as well as cancerogenesis in the mamma have been presented. Also the newest information about the safety of hormone therapy in the group of breast cancer survivors has been quoted. Being of opinion that at present only estrogens are able to treat climacteric symptoms completely, the authors are sharing their opinion about an important role to be played in menopause by the well-tailored, low-dose (25 mg and 37,5 μg 17β-E₂/day), transdermal estrogen therapy.